Repurposing of approved drugs from the human pharmacopoeia to target Wolbachia endosymbionts of onchocerciasis and lymphatic filariasis
Lymphatic filariasis and onchocerciasis are debilitating diseases caused by parasitic filarial nematodes infecting around 150 million people throughout the tropics with more than 1.5 billion at risk. As with other neglected tropical diseases, classical drug-discovery and development is lacking and...
Main Authors: | Kelly L. Johnston, Louise Ford, Indira Umareddy, Simon Townson, Sabine Specht, Kenneth Pfarr, Achim Hoerauf, Ralf Altmeyer, Mark J. Taylor |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-12-01
|
Series: | International Journal for Parasitology: Drugs and Drug Resistance |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211320714000244 |
Similar Items
-
Anti-Wolbachia therapy for onchocerciasis & lymphatic filariasis: Current perspectives
by: Wan Aliaa Wan Sulaiman, et al.
Published: (2019-01-01) -
Detection of Canine Vector-Borne Filariasis and Their <i>Wolbachia</i> Endosymbionts in French Guiana
by: Younes Laidoudi, et al.
Published: (2020-05-01) -
AmiD Is a Novel Peptidoglycan Amidase in Wolbachia Endosymbionts of Drosophila melanogaster
by: Miriam Wilmes, et al.
Published: (2017-08-01) -
Wolbachia: endosymbiont of onchocercid nematodes and their vectors
by: Ranju Ravindran Santhakumari Manoj, et al.
Published: (2021-05-01) -
Effects of Doxycycline on gene expression in <it>Wolbachia </it>and <it>Brugia malayi </it>adult female worms in vivo
by: Rao Ramakrishna U, et al.
Published: (2012-02-01)